Oyster Point Pharma

Home » Oyster Point Pharma

IPO

Oyster Point Pharma

Biopharmaceutical

We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.

Symbol

OYST

Price Range
$16.00 - $18.00

Final Shares
5,000,000

Anticipated Date
October 31, 2019

Underwriters
J.P. MORGAN SECURITIES LLC,COWEN AND COMPANY, LLC,PIPER JAFFRAY & CO.

This offering is no longer available

To view the prospectus for Oyster Point Pharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253